Jennifer Viera
Contacto de Relaciones con Inversores en ENANTA PHARMACEUTICALS, INC. .
Cargos activos de Jennifer Viera
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | 01/01/2023 | - |
| Public Communications Contact | 01/01/2023 | - |
Historial de carrera de Jennifer Viera
Antiguos cargos conocidos de Jennifer Viera.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | - | - |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Viera
- Experiencia
